Tammy M Kuang1, Chunwei Zhang2, Linda M Zangwill3, Robert N Weinreb3, Felipe A Medeiros4. 1. Hamilton Glaucoma Center and Department of Ophthalmology, University of California, San Diego, La Jolla, California; Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang-Ming University, Taipei, Taiwan. 2. Hamilton Glaucoma Center and Department of Ophthalmology, University of California, San Diego, La Jolla, California; Department of Ophthalmology, First Affiliated Hospital, Harbin Medical University, Harbin, China. 3. Hamilton Glaucoma Center and Department of Ophthalmology, University of California, San Diego, La Jolla, California. 4. Hamilton Glaucoma Center and Department of Ophthalmology, University of California, San Diego, La Jolla, California. Electronic address: fmedeiros@ucsd.edu.
Abstract
PURPOSE: To estimate the diagnostic accuracy and lead time gained by retinal nerve fiber layer (RNFL) thickness measurements from optical coherence tomography (OCT) for detecting glaucoma before the development of visual field defects. DESIGN: Observational cohort study. PARTICIPANTS: The study group included 75 eyes of 75 patients suspected of having glaucoma. These eyes had normal standard automated perimetry (SAP) at baseline and demonstrated repeatable (3 consecutive) abnormal tests during a median follow-up of 6.3 years. A control group of 75 eyes of 75 healthy subjects matched by age and number of OCT tests during follow-up was included. METHODS: The RNFL thickness measurements were obtained at the time of development of the earliest SAP defect (time 0) and also at times -1, -2, -3, and so forth, corresponding to 1 year, 2 years, 3 years, and so forth, before the development of field loss. The OCT measurements at corresponding intervals were analyzed for controls. Time-dependent receiver operating characteristic (ROC) curves were used to evaluate diagnostic accuracy of OCT. MAIN OUTCOME MEASURES: Areas and sensitivities of ROC curve at fixed specificities at different times before development of field loss. RESULTS: At the date of conversion to the earliest visual field defect (time 0), mean ± standard deviation average RNFL thickness was 75.0±9.8 μm in glaucomatous eyes and 90.6±8.0 μm for controls (P < 0.001). Significant differences were seen up to 8 years before development of visual field defects (86.3±8.2 μm vs. 91.4±7.6 μm, respectively; P = 0.021). The ROC curve areas decreased with increasing times before detection of field defects. At times 0, -4, and -8 years, ROC curve areas were 0.87, 0.77, and 0.65, respectively. At 95% specificity, up to 35% of eyes had abnormal average RNFL thickness 4 years before development of visual field loss and 19% of eyes had abnormal results 8 years before field loss. CONCLUSIONS: Assessment of RNFL thickness with OCT was able to detect glaucomatous damage before the appearance of visual field defects on SAP. In many subjects, significantly large lead times were seen when applying OCT as an ancillary diagnostic tool.
PURPOSE: To estimate the diagnostic accuracy and lead time gained by retinal nerve fiber layer (RNFL) thickness measurements from optical coherence tomography (OCT) for detecting glaucoma before the development of visual field defects. DESIGN: Observational cohort study. PARTICIPANTS: The study group included 75 eyes of 75 patients suspected of having glaucoma. These eyes had normal standard automated perimetry (SAP) at baseline and demonstrated repeatable (3 consecutive) abnormal tests during a median follow-up of 6.3 years. A control group of 75 eyes of 75 healthy subjects matched by age and number of OCT tests during follow-up was included. METHODS: The RNFL thickness measurements were obtained at the time of development of the earliest SAP defect (time 0) and also at times -1, -2, -3, and so forth, corresponding to 1 year, 2 years, 3 years, and so forth, before the development of field loss. The OCT measurements at corresponding intervals were analyzed for controls. Time-dependent receiver operating characteristic (ROC) curves were used to evaluate diagnostic accuracy of OCT. MAIN OUTCOME MEASURES: Areas and sensitivities of ROC curve at fixed specificities at different times before development of field loss. RESULTS: At the date of conversion to the earliest visual field defect (time 0), mean ± standard deviation average RNFL thickness was 75.0±9.8 μm in glaucomatous eyes and 90.6±8.0 μm for controls (P < 0.001). Significant differences were seen up to 8 years before development of visual field defects (86.3±8.2 μm vs. 91.4±7.6 μm, respectively; P = 0.021). The ROC curve areas decreased with increasing times before detection of field defects. At times 0, -4, and -8 years, ROC curve areas were 0.87, 0.77, and 0.65, respectively. At 95% specificity, up to 35% of eyes had abnormal average RNFL thickness 4 years before development of visual field loss and 19% of eyes had abnormal results 8 years before field loss. CONCLUSIONS: Assessment of RNFL thickness with OCT was able to detect glaucomatous damage before the appearance of visual field defects on SAP. In many subjects, significantly large lead times were seen when applying OCT as an ancillary diagnostic tool.
Authors: Mauro T Leite; Linda M Zangwill; Robert N Weinreb; Harsha L Rao; Luciana M Alencar; Pamela A Sample; Felipe A Medeiros Journal: Invest Ophthalmol Vis Sci Date: 2010-03-24 Impact factor: 4.799
Authors: Gadi Wollstein; Joel S Schuman; Lori L Price; Ali Aydin; Paul C Stark; Ellen Hertzmark; Edward Lai; Hiroshi Ishikawa; Cynthia Mattox; James G Fujimoto; Lelia A Paunescu Journal: Arch Ophthalmol Date: 2005-04
Authors: Felipe A Medeiros; Linda M Zangwill; Douglas R Anderson; Jeffrey M Liebmann; Christopher A Girkin; Ronald S Harwerth; Marie-Josée Fredette; Robert N Weinreb Journal: Am J Ophthalmol Date: 2012-07-27 Impact factor: 5.258
Authors: Atsuya Miki; Felipe A Medeiros; Robert N Weinreb; Sonia Jain; Feng He; Lucie Sharpsten; Naira Khachatryan; Na'ama Hammel; Jeffrey M Liebmann; Christopher A Girkin; Pamela A Sample; Linda M Zangwill Journal: Ophthalmology Date: 2014-03-13 Impact factor: 12.079
Authors: Felipe A Medeiros; Renato Lisboa; Robert N Weinreb; Christopher A Girkin; Jeffrey M Liebmann; Linda M Zangwill Journal: Arch Ophthalmol Date: 2012-09
Authors: Gianmarco Vizzeri; Madhusudhanan Balasubramanian; Christopher Bowd; Robert N Weinreb; Felipe A Medeiros; Linda M Zangwill Journal: Opt Express Date: 2009-03-02 Impact factor: 3.894
Authors: Renato Lisboa; Kaweh Mansouri; Linda M Zangwill; Robert N Weinreb; Felipe A Medeiros Journal: Am J Ophthalmol Date: 2013-08-20 Impact factor: 5.258
Authors: Paula A Alhadeff; Carlos G De Moraes; Monica Chen; Ali S Raza; Robert Ritch; Donald C Hood Journal: J Glaucoma Date: 2017-05 Impact factor: 2.503
Authors: Alberto Diniz-Filho; Ricardo Y Abe; Linda M Zangwill; Carolina P B Gracitelli; Robert N Weinreb; Christopher A Girkin; Jeffrey M Liebmann; Felipe A Medeiros Journal: Ophthalmology Date: 2016-08-20 Impact factor: 12.079